doi: 10.1016/j.tcb.2023.07.003
P-LLY Lilly Cautionary Statement Regarding Forward-Looking Statements This press release contains forward-looking statements (as that term is defined in the Private Securities Litigation Reform Act of 1995) about tirzepatide as a potential treatment for people with type 2 diabetes and the timeline for future readouts, presentations and other milestones relating to tirzepatide and its clinical trials and reflects Lilly's current belief and expectations
Usage:For in vitro research and laboratory investigation only
While the medication has been hailed as a potential game-changer for some people looking to manage their weight and related health conditions, it can come with unwanted side effects that patients should be aware of before starting treatment
You might NOT be able to take GLP-1 if you have a history of pancreatitis, kidney disease/kidney insufficiency, Stomach problems, diabetes (must be approved from endocrinologist) or gall bladder disease
Johnson, who describes himself as a "Professional Rejuvenation Athlete," has developed a rigorous regimen that integrates cutting-edge biotechnology with a meticulously designed lifestyle program aimed at reversing aging